Ineos Grenadiers' Adam Yates and all of Team Jumbo-Visma will not make an appearance at the start of the fifth stage of the Tour de Suisse due to COVID-19.
Despite taking all of the necessary precautions and protection, a rider on Team Jumbo-Visma has tested positive.
The decision to withdraw was “in the interest of the health of the riders and staff and to protect the peloton and the race” says the team, with the Tour de Suisse management factoring in on the decision.
Ganna signs four-year contract extension with Ineos Grenadiers
The team has not revealed which rider was infected with Covid-19, nor any of the details surrounding their current physical state, but they confirmed that as of right now, no changes have been made to the current Tour de France squad.
However, the situation regarding the upcoming Grand Tour will be reassessed in the coming days.
Later in the day, Ineos Grenadiers confirmed that Yates, who was sitting 10th overall after four stages of the Tour de Suisse, left the team "after experiencing mild symptoms and returning a positive lateral flow test."
- Highlights: Impey claims ‘huge, huge’ win at Tour de Suisse
- ‘We have had some stories! - Impey seals comeback win with Tour de Suisse success
- 'The first big goal is the yellow jersey' - Ganna on his Tour de France ambitions
Jumbo-Visma has confirmed that there was no relaxation of Covid-19 rules and regulations, with everyone in the camp doing daily testing, as well as the common use of mouth masks, air purification columns and individual rooms.
Despite these precautions, the team has had Covid-19 issues since the turn of the year, with their training camp being forced to close in January, and both Wout van Aert and Marianne Vos missing out on races due to catching the virus.
- - -
Stream top cycling action live and on-demand on discovery+
Tour de France Femmes
‘You have to be realistic’ – Vos under no illusions over keeping yellow jersey
Tour de France
'I hear what people say about me' - Laporte frustrated at doping questions
Share this article